2008Unpublished venueRequires access

Expression of p170 and p53 in breast cancer and clinical significance

Chang Zhi-kun

Open publisher page 0 citations

Abstract

Objective:To investigate the expression of p170 and p53 in breast cancer ,and to explore their relationship and clinical significance. Methods: Immunostaining ( S-P ) was performed for p170 and p53 on 96 specimens of breast cancer. Results: The rate of positive expression of p170 was 65.25% (54/96) , which had no correlation with age, tumor size ,axillas lymph nodes metastasis , pathological grades, pathological classification and expression of ER,PR . The positive expression rate of p53 was 41.67% ( 40/96 ), which had correlation with the historical grades, had no correlation with age , tumor size , axillas lymph nodes metastasis , pathological classification and expression of ER,PR. The expression rate of p170 had positive correlation with p53. Conclusion: The expression rate of p170 had a positive correlation with p53. They were important pathological signs of the breast cancer. These markers play an important role in choosing clinical chemotherapy drugs.

About this research paper

What this paper is about

Objective:To investigate the expression of p170 and p53 in breast cancer ,and to explore their relationship and clinical significance. Methods: Immunostaining ( S-P ) was performed for p170 and p53 on 96 specimens of breast cancer. Results: The rate of positive expression of p170 was 65.25% (54/96) , which had no correlation with age, tumor size ,axillas lymph nodes metastasis , pathological grades, pathological classification and expression of ER,PR . The positive expression rate of p53 was 41.67% ( 40/96 ), which had correlation with the historical grades, had no correlation with age , tumor size , axillas lymph nodes metastasis , pathological classification and expression of ER,PR. The expression rate of p170 had positive correlation with p53. Conclusion: The expression rate of p170 had a positive correlation with p53. They were important pathological signs of the breast cancer. These markers play an important role in choosing clinical chemotherapy drugs.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the expression of p170 and p53 in breast cancer ,and to explore their relationship and clinical significance. Methods: Immunostaining ( S-P ) was performed for p170 and p53 on 96 specimens of breast cancer. Results: The rate of positive expression of p170 was 65.25% (54/96) , which had no correlation with age, tumor size ,axillas lymph nodes metastasis , pathological grades, pathological classification and expression of ER,PR . The positive expression rate of p53 was 41.67% ( 40/96 ), which had correlation with the historical grades, had no correlation with age , tumor size , axillas lymph nodes metastasis , pathological classification and expression of ER,PR. The expression rate of p170 had positive correlation with p53. Conclusion: The expression rate of p170 had a positive correlation with p53. They were important pathological signs of the breast cancer. These markers play an important role in choosing clinical chemotherapy drugs.

Key concepts: Pathological, Breast cancer, Medicine, Correlation, Clinical significance, Immunostaining, Positive correlation, Metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of p170 and p53 in breast cancer and clinical significance — Research Paper | ScholarLens